The accurate diagnosis of rhinologic disease depends on the clinical history, examination findings and, in many cases, further investigations. There are a wide variety of diagnostic tests available, the choice of which depends upon the condition being assessed. This position paper is intended to provide an up-to-date comprehensive description of the diagnostic tools available to rhinologists, allergists, general otolaryngologists and other physicians with an interest in sinonasal disease. The literature has been reviewed and evidence-based recommendations are included. The relevant history and examination techniques are described, including endoscopic assessment of the nose. General and disease-specific quality of life instruments are an important tool in assessing the impact of rhinologic disease and the response to treatment. Relevant blood tests are discussed, as well as the various methods of allergy testing. Techniques for collecting microbiological and tissue samples are described, as well as the use of more specialised tests such as nasal nitric oxide and those evaluating ciliary structure and function. Imaging techniques and their indications are included. Chemosensory (smell and taste) testing is explained, and the available techniques for objective measurement of nasal airflow and patency are reviewed. Prompt and accurate diagnosis allows appropriate management to be initiated; an understanding of the currently available diagnostic tools is a vital part of the assessment of rhinologic disease.
Introduction
The European Academy of Allergy and Clinical Immunology (EAACI) recognised the importance of accurate investigation in the diagnosis of sinonasal disease with their 2011 position paper on Diagnostic Tools in Rhinology (1) . That document hoped to 'become outdated soon by new advances in the field' -this has indeed been the case in some areas, whilst others remain unchanged. This position paper is intended to provide an up-to-date comprehensive description of the diagnostic tools available to rhinologists, allergists, general otolaryngologists and other physicians with an interest in sinonasal disease.
Some rhinologic conditions can be diagnosed on history and examination alone; others require further investigations to confirm or, in some cases, exclude a diagnosis. Blood tests, microbiology and histology, imaging, airflow assessment, allergy testing and more specialised investigations may all play a role.
The accurate diagnosis of rhinologic disease is important for various reasons. Many sinonasal conditions have a significant negative impact on patients' quality of life (QOL), and prompt diagnosis will allow appropriate management at an early stage, with subsequent improvement in outcomes (2) . Inflammatory airway disease often starts in the nose and progresses to the lower respiratory tract, and there are several systemic conditions that may initially present with sinonasal symptoms, including cystic fibrosis, granulomatous and vasculitic conditions. Some systemic conditions are associated with significant potential long-term morbidity and even mortality which can be prevented or ameliorated by early accurate diagnosis and treatment.
In some healthcare systems, objective evidence of disease and proof of benefit from treatment is increasingly required for funding purposes. This is particularly true for surgical intervention but also for newer, more expensive medical treatments such as monoclonal antibodies for asthma, nasal polyps and systemic vasculitides. Accurate diagnosis can be facilitated by appropriate investigations, remembering that not all the tests discussed below will be relevant to all patients. Some are freely available for all to use, others require more specialist equipment, and some remain more in the realm of research than clinical practice.
Nonetheless, we must ensure that the available tools are used to facilitate prompt diagnosis and management of the multitude of sinonasal conditions that we see in our patients every day.
History and examination
Rationale History taking and examination techniques are among the first clinical skills learned and remain the most important part of a consultation. A thorough history and rhinologic examination will suggest a differential diagnosis and, in some cases, may give an exact diagnosis. Certain rhinologic conditions, such as rhinosinusitis, have established diagnostic criteria, and treatment can be commenced based on the symptoms and clinical findings alone (3, 4) .
There are a limited number of rhinological symptoms; when these are taken together with examination findings, a diagnosis may be made. If that is not possible, the investigations required to confirm (or exclude) a disease can be determined. Several studies have assessed the correlation between symptoms, examination findings and imaging results in chronic rhinosinusitis (CRS) (5) (6) (7) . If symptom criteria are met there is a high sensitivity but low specificity for correctly diagnosing CRS. If endoscopy is included, the specificity and diagnostic accuracy increase significantly (6, 7) .
Objectives
To establish the nature, duration and severity of symptoms, and to interpret them in conjunction with examination findings, with the aim of making a diagnosis and initiating appropriate treatment. If an exact diagnosis cannot be reached then further investigations may be indicated, depending on the symptoms and clinical findings.
History
Patients should be asked to describe their symptoms, and further questions can then define their nature. Common sinonasal symptoms are listed in Box 1. It is useful to identify any precipitating or relieving factors, including any response (or lack of ) to treatment so far (8) .
Nasal obstruction or congestion is the most common rhinologic symptom, reported in up to 80% of patients (9) . It may be unilateral or bilateral, fluctuating, alternating or constant, and is a very subjective symptom. The nature of the obstruction can suggest the underlying aetiology, for example unilateral constant nasal obstruction is often due to septal deviation, whilst alternating fluctuating obstruction is more typical of rhinitis.
Nasal discharge (rhinorrhoea) may be anterior or posterior, with many patients describing 'postnasal drip'; this may simply be an awareness of the normal passage of mucus posteriorly from the nose into the pharynx but may represent an abnormal volume or consistency of mucus. It may be clear and watery, as commonly seen in rhinitis, although unilateral watery rhinorrhoea should raise the suspicion of a CSF leak. Discharge may be coloured, although this does not always correlate with an infective aetiology. Blood-stained discharge may simply be due to underlying inflammation or infection but a neoplastic or vasculitic process must be considered.
Facial pressure or pain may be related to underlying sinonasal disease, particularly acute exacerbations, but many so-called SUPPLEMENT 28 4 rhinoscopy alone, up to 69.1% -85% (5, 6) . It is highly specific, with several studies reporting specificities of up to 95% (6, 7, 20) . It is less sensitive, ranging from 30% to 73% (5) (6) (7) . Various endoscopic scoring systems have been described, such as the Lund-Kennedy system and modifications thereof (21, 22) . Inter-rater reliability is variable, with some aspects of the examination scoring highly and others less so, although overall inter-rater agreement is good (23) (24) (25) (26) (27) .
Posterior rhinoscopy and diaphanoscopy have been superseded by endoscopy and imaging.
Recommendations
A thorough history should be used in combination with a complete rhinological examination, of which endoscopy is a vital part. This allows a systematic approach to be used to determine the differential diagnosis, whether further investigations are required, and to plan appropriate management for the individual patient.
Nasal congestion/obstruction Nasal discharge Facial pain/pressure or headache Change in sense of smell Sneezing/itching Bleeding Box 1. Common sinonasal symptoms. Figure 2 . First pass with rigid (0 degree) endoscope. Figure 3 . Second pass with rigid (0 degree) endoscope.
Quality of life instruments
Rationale Sinonasal diseases can have a significant impact upon patients'
QOL. This affects physical and mental health and may translate into absenteeism or presenteeism. The effects on daily functioning, work, leisure and school as perceived by the patient are considered an important characteristic of disease severity (28, 29) .
Therefore, assessment of QOL is one of the standard outcome measures that is increasingly important to improving patientcentred care and optimising healthcare delivery.
Patients seek medical care in order to alleviate symptoms of disease and their impact on QOL. It seems intuitive that doctors would wish to measure whether they are successful in achieving these treatment aims, whether from surgical or medical intervention. Medical therapy is often the mainstay of treatment for sinonasal disease, but if this fails or complications arise, surgery is considered. Therefore, patients have several treatment options which may change and evolve throughout their disease progression. The degree of health-related QOL impairment has been demonstrated to drive patient choice between treatment options (30) . Application of different outcome measures is essential to improve the quality of care. Moreover, assessment of QOL is one of the standard outcome measures in clinical trials, acknowledging the fact that the classical outcome variables may only partially characterize the disease of the patient.
Objectives
To evaluate the degree of QOL impairment due to rhinological disease, to help guide treatment and to monitor the response to medical and/or surgical management. Additional benefits to measuring surgical outcome are listed in Box 2.
Patient-rated outcome measures (PROMs)
Quality of life is measured using one of a growing number of validated 'instruments'; typically these are questionnaires, but in some cases visual scales or grading systems can be used. These allow quantitative assessment of otherwise subjective results.
So why not simply ask the patients if they are satisfied with their treatment? Although this is easy to do, patient satisfaction is influenced by many variables, such as the availability and convenience of healthcare, the 'bedside manner' of the doctor, affability of the extended team and perceived cleanliness of the hospital (31) . (32) .
The EQ-5D is a generic measure of a patient's preference for living in a particular health state. It has been recently validated in the CRS population and provides health state utility values capable of generating quality-adjusted life-years (33, 34) . The EQ-5D contains five attributes: mobility; self-care; usual activity; pain/ discomfort; and anxiety/depression. Each attribute has three possible states, which provides 245 possible health states. Utility scores were measured for each health state using the time trade-off technique (34, 35) .
Generic QOL instruments should be used with caution to assess changes in health-related QOL and are less effective with mild disease (36) . For example, when applied to cataract surgery, a pilot study found that although the majority of patients reported that their vision was better following cataract surgery, there was no change in the EQ-5D (37) . Similar results have been shown in patients with conductive hearing loss (38) . This is of concern if such measures are used for demand management to ration healthcare. Furthermore, application of these different instruments in the same patient group can yield significantly different results (39) .
Disease-specific PROMs
There are a number of disease-specific QOL instruments that have been developed to assess the most important symptoms for patients and quantify the severity of all commonly associa- 
Chronic rhinosinusitis
A recent systematic review performed by Rudmik et al. (40) identified 15 PROMs validated for adults with CRS. Of these, (43) . This is the largest published outcomes study to date in CRS, and therefore provides useful benchmarking data against which future studies may be compared. Psychometric validation has been completed, suggesting excellent internal consistency, test-retest reliability and discriminant ability, and has established that the minimally important change for an individual with CRS is nine points (44) .
Rhinitis
The mini-Rhinoconjunctivitis Quality of Life Questionnaire (mini-RQLQ) was primarily developed and validated to assess QOL in allergic rhinitis and includes 14 questions divided into five subdomains assessing daily activities, practical issues, and nasal and ocular symptoms (45) . In contrast to the well-known significant impairment of QOL in allergic rhinitis, the degree of impairment in QOL in non-allergic rhinitis remained unknown for a long time, due to the lack of a validated questionnaire. Recently, a validation of the mini-RQLQ questionnaire in non-allergic rhinitis patients was performed, followed by an assessment of QOL in non-allergic rhinitis patients compared to allergic rhinitis patients and healthy controls (46) .
Nasal obstruction and septal surgery
The Nasal Obstruction Septoplasty Effectiveness (NOSE) questionnaire is a validated five-item instrument for use in patients with nasal obstruction, and has been used to measure improvements in QOL after septoplasty, functional septorhinoplasty and nasal valve surgery (47) . The SNOT-22 has also been used in septoplasty, although it has not been validated in this patient group (48 .
Rhinoplasty and facial appearance
Perhaps more so than in any other aspect of rhinology, patient satisfaction and QOL must be the measure against which successful aesthetic facial plastic surgery should be judged. A recently published study identified 47 patient-reported instruments targeted to facial plastics (49) . Three of these pertained to rhinoplasty (Glasgow Benefit Inventory, Facial Appearance Sorting Test (50) and the Rhinoplasty Outcomes Evaluation (ROE)) (51) . The ROE is the only QOL instrument designed specifically for rhinoplasty and has been fully validated. There are few published studies including patient-rated satisfaction following rhinoplasty. Two studies show significant improvement in ROE scores following rhinoplasty (51, 52) .
Skull base surgery
A disease-specific instrument has been designed and validated for those undergoing resection of anterior skull base tumours (53) . The Anterior Skull Base Questionnaire (ASBQ) has a total of 35 items including generic questions and items drawn from head and neck questionnaires, and also includes more detailed questions regarding altered taste, smell, appearance, epiphora, nasal secretions and visual disturbances (53) .
Recommendations
Patients now rightly expect their doctors to record outcomes of clinical care. Clinical measures are becoming more sophisticated, and the equipment required to make such measures is now widely available. Routine collection of PROMs is likely to become mandatory for healthcare providers. We should embrace this opportunity and use this patient-rated information to enhance the doctor-patient relationship and focus communication. Careful use in cohort studies or within randomised trials may identify important differences in outcomes between treatments or providers, although it is still important to recognise the limitations of the outcome tools.
Blood tests

Rationale
Blood tests are required for some patients with rhinological conditions. However, before tests are requested, it should be asked whether they are likely to be materially helpful in the diagnosis and management of the patient. If tests with imperfect accuracy are requested for patients with a low pre-test probability of having the condition, then more diagnostic confusion can be created by false positive results than diagnostic clarity by true positive results.
Objectives
To provide additional support for or against the diagnosis of certain rhinological conditions, and to monitor disease severity, progression and/or response to treatment where appropriate.
Epistaxis
A full blood count, serum ferritin and coagulation studies may be included in the investigation of recurrent or severe epistaxis.
Rhinitis
Allergic rhinitis
Diagnostic tests for allergies must be considered when the clinical presentation indicates a high suspicion of immunoglobulin E (IgE)-mediated disease (see section on 'Allergy tests'). It is important to highlight that allergy testing demonstrates sensitization to a specific allergen, which does not always imply clinical manifestations of that sensitization (54, 55) . Despite their relatively high cost compared to skin prick tests (SPT), tests that measure serum levels of allergen specific IgE are a valuable alternative for patients with a high risk of anaphylaxis, severe eczema or other dermatologic diseases, or when the interruption of anti-histamines is contraindicated (56) .
Non-infectious non-allergic rhinitis
The investigation of systemic conditions such as pregnancy, thyroid pathologies and autoimmune diseases should be considered in appropriate clinical contexts.
Granulomatous and vasculitic rhinological conditions
Vasculitic diseases with sinonasal manifestations usually, but not always, involve multiple organs. Rhinitis, sinusitis, septal perforation and epistaxis are the most common nasal features related to these diseases (57) .
Granulomatosis with polyangiitis (GPA, formerly Wegener's granulomatosis)
Patients with granulomatosis with polyangiitis (GPA) affecting the sinonasal cavity usually have persistent bleeding, crusting and obstruction, and may develop a septal perforation.
Sometimes the manifestations of this vasculitic condition are limited to the sinonasal cavity. GPA is strongly associated with anti-neutrophil cytoplasmic antibodies (ANCA), and the more widespread and severe the presentation, the more likely the serum ANCA is to be positive (58) . The combination of clinical features, positive ANCA serology, necrotizing vasculitis and granulomatous inflammation on biopsy establish the diagnosis (59) . However, nasal biopsies often do not have enough features specific to this condition to confirm the diagnosis, and so biopsies from other involved organs may be required.
It is important to highlight that a positive ANCA serology is not required for diagnosis if the clinical and histological findings are consistent with GPA. The sensitivity of this test is lower for localized as opposed to generalised GPA. False positive ANCA results can also occur. The cytoplasmic antigen towards which ANCAs are directed is proteinase-3 (PR3), and the detection of PR3 antibodies in serum by enzyme-linked immunosorbent assay (ELISA) is used in conjunction with ANCA immunofluorescent testing to improve diagnostic accuracy (60, 61) .
Eosinophilic granulomatosis with polyangiitis (EGPA, formerly
Churg-Strauss syndrome)
Eosinophilic granulomatosis with polyangiitis (EGPA) is a necrotizing vasculitis of small and medium-sized vessels. Among a wide spectrum of non-pulmonary symptoms, nasal and sinonasal features are common and part of the diagnostic criteria for EGPA (62) . This condition typically develops in patients with adult onset asthma and the sinonasal manifestation is CRS with eosinophilic nasal polyps.
Like GPA, EGPA is associated with positive ANCA serology. The most common pattern of immunofluorescence seen is a perinuclear (as opposed to a cytoplasmic) pattern. The antigen to which the antibodies are most commonly directed in EGPA is myeloperoxidase (MPO), and serum ELISAs for MPO are positive in about 40% -50% of patients with this disease (63) .
Sarcoidosis
Sarcoidosis is a complex disease with manifold clinical manifes- used laboratory test for the investigation of sarcoidosis (64) . Elevated serum levels of ACE, sIL-2R and lysozyme are usually associated with more aggressive disease and multiple organ involvement (65) .
Infectious conditions
Diagnostic tests for human immunodeficiency virus (HIV), tuberculosis, syphilis and hepatitis should be considered in patients with high-risk exposure to infectious diseases.
Immunoglobulin deficiencies
Patients with hypogammaglobulinaemia often present with a 
Miscellaneous blood tests
Periostin
Periostin is both an extracellular matrix protein and matricellular protein that is capable of activating cells by linking integrin molecules to cell receptors, promoting tissue remodelling. It may be an important biomarker for type 2 immunity and airway allergic inflammation exacerbations. Up-regulated expression of periostin is correlated with CRS with nasal polyps (CRSwNP) and
Th2-type asthma (66) (67) (68) . Serum periostin levels also appear to be higher in patients with NSAID intolerance than in those without it (67) .
Aspirin sensitivity
Oral provocation test is the most common investigation used to identify hypersensitivity reactions to aspirin. However, for those patients who have a higher risk of severe reactions, flow cytometry-assisted basophil activation testing (FAST) and functional-eicosanoid-test (FET) can be helpful tools to elucidate the diagnosis, if they are available (69, 70) .
Recommendations
Many patients with nasal conditions are managed with clinical evaluation including endoscopy and imaging, without the requirement for blood tests. However, for some presentations laboratory tests are very helpful.
Allergy tests
Rationale
Allergic rhinitis in most cases is triggered by allergen-specific (71) . The prevalence of positive skin prick or serum allergy tests are significantly higher than the prevalence of allergic rhinitis, so testing patients with a low pretest probability of having this condition will generate false positive results.
Objectives
To demonstrate both the presence and functional relevance of IgE antibodies in allergic rhinitis.
Skin tests
In patients with upper airway allergies, skin tests such as SPT and intracutaneous tests (ICT) are the most commonly used in vivo methods to diagnose IgE-mediated allergic reactions (72) (73) (74) (75) (76) . A recent EAACI task force survey investigating the current practice of allergy diagnosis in Europe found that in almost twothirds of all types of allergic diseases and in 90% of respiratory allergies the diagnosis relies on skin tests as the first option (77) .
A number of manufacturers offer commercial allergen test extracts for skin testing called diagnostic allergens (DAs).
The composition and standardization of DAs is crucial to the sensitivity, specificity and reproducibility of test results (75, 78) . In the European Union (EU), allergens used for diagnostic tests or therapy have been defined as medicinal products by EU Directives 89/342/EEC and 2001/83/EC (78) . As such, DAs that are produced by an industrial process to be used in the EU are required to obtain a marketing authorisation in EU member states. For this, the documentation to be provided by the applicant has to follow the European Pharmacopoeia as well as specific guidelines such as those developed by the European Medicines Agency and the International Council for
Harmonisation of Technical Requirements for Pharmaceuticals
for Human Use (75, 78) . For allergen products, the Guideline on Allergen Products: Production and Quality Issues is of high importance (79) . The approval of DAs has enabled the use of qualitatively and quantitatively standardized extracts (75, 78) , however it also increased the costs for and has led to a reduction in commercially available DAs (75, 78, 80) .
Skin prick test (SPT)
The primary diagnostic tool to detect type I hypersensitivity reactions in the upper airways is SPT, since it is reproducible, inexpensive, safe, minimally invasive and results are immediately available (74, (81) (82) (83) (84) . SPT interpretation utilizes the presence and degree of cutaneous reactivity as a surrogate marker for sensitization within target organs and allows several different allergens to be tested simultaneously. A large GA2LEN study in 14 countries set a standard allergen panel for SPT (83, 85) . The allergen is presented to perivascular mast cells in the dermis; the volar side of the forearm is the preferred site (86) , but modifications exist for special applications (87) . The test site should be marked so that individual reactions can be readily Redness (erythema) and wheal (urticaria) peak within 15-20 minutes following histamine or allergen application (88) . Latephase reactions may appear within hours to several days after SPT.
Intracutaneous test (ICT)
Using a 21-gauge needle, 0.02−0.05 ml of the test solution is injected intracutaneously (86) ; the injected volume should form a wheal approximately 3 mm in diameter. The test solution must be sterile and both approved and suitable for intracutaneous use (89) . ICT may have higher sensitivity but lower specificity compared with SPT and require different allergen test solution concentrations (90) (91) (92) (93) . Thus, ICT may be indicated even in the presence of a negative SPT (90) (91) (92) (93) .
Provocation tests
Nasal allergen challenge
The EAACI guidelines for nasal allergen challenge testing aim to unify the conduction of provocation tests and their interpretation (94) . The main recommendations are a bilateral challenge with standardized allergens using a spray device offering 0.1 mL per puff. A systematic catalogue for positivity criteria is given for the variety of established subjective and objective assessment methods as well as a schedule for the challenge procedure.
Conjunctival provocation test (CPT)
Most patients with allergic rhinitis also suffer from allergic conjunctivitis, with symptoms of itchy eyes, redness and tearing (95 (Tables 1-3 ). If the CPT is positive, the eye is rinsed with lukewarm water and drops containing topical antihistamines or nonpharmacological agents are applied for symptom relief. If the threshold of the scoring system is not reached, the CPT is repeated with a higher allergen concentration, for example increased by a factor of 10 ( Figure 5 ). The CPT is considered negative if no reaction occurs after the highest concentration has been administered.
The total ocular symptom score (TOSS) ( Table 1) is calculated by adding up the individual scores and is positive if the sum is greater than five (96) .
Riechelmann et al. (97) established an adapted version of the scoring system described by Gronemeyer (98) by comparing the CPT with the nasal provocation test (NPT), SPT, IgE assays and the patient's allergic history ( Table 2 ). The allergic reaction is classified as stages 0-IV; stage II or higher is considered positive. In comparison with the NPT, the CPT assessed with the Gronemeyer score was shown to be more consistent with the SPT, IgE assays and the allergic history (97) . The CPT can also be used in patients with allergic rhinitis but no conjunctival symptoms.
The culture-independent assessment of the CPT (CIA-CPT) is applied to the separate allergic symptoms of the CPT, assessing them on a 0-3 scale (Table 3) , and was successfully used in a recent dose-finding study (99) . The information obtained depends on the quality of the allergen solution. It is recommended to use only highly standardized and lyophilized allergen extracts and a fluid containing only one allergen (96) . Depending on the manufacturer, definitions authorizations in each country granting them (78) .
In vitro allergy testing (IgE)
IgE antibodies are the major contributors in type 1 allergic diseases, but as such are also a marker of disease. Serological tests for allergen-specific IgE antibodies have been in clinical use for several decades (100) (101) (102) . In general, the correlation between a strongly positive response to a skin test and the detection of serum-specific IgE, and between a negative response to a skin test and the lack of detection of serum-specific IgE, is very good.
As with skin tests, the presence or absence of specific IgE in the serum does not automatically imply a clinically relevant allergy.
The composition and quantity of antigens within an allergenic extract strongly affects the result of traditional extract-based IgE assays (103) . Commercial IgE assays produced by different companies may therefore generate different quantitative levels and non-concordant qualitative results (101) .
Rationales supporting the targeted use of allergen molecules include increased test sensitivity, particularly when important allergens are underrepresented or lacking commercial extracts, improved test selectivity/analytical specificity, possible crossreactivity and primary (species-specific) sensitization. Allergenspecific IgE tests identifying allergenic antigens at a molecular basis are thus considered a more precise and informative option compared to tests based on allergenic extracts (104) . This analytical approach is called "component resolved diagnosis"
(CRD) and allows detailed molecular profiling of the polyclonal IgE repertoire of the allergic patient (101, (104) (105) (106) (107) . Several single molecular allergens of clinical relevance have been identified, characterized and produced for commercial in-vitro assays and will allow for precision medicine approaches (108, 109) . Databases of allergenic molecules help allergists to handle and interpret CRD data (110, 111) . Today, IgE microarrays exist that measure more Table 1 . Total ocular symptom score (TOSS) (96) . Table 2 . Adapted version of the Gronemeyer scoring system (97) .
Stage
Symptom Severity (score)
Itching 0 -no itching 1 -mild itching, but not annoying 2 -moderate , annoying itching or urge to rub the eye sometimes 3 -severe , very annoying itching or urge to rub the eye frequently. Table 3 . Culture-independent assessment of the CPT (CIA-CPT) (99) . This section will provide an overview of historical and current microbial sampling techniques as well the rationale for their use. In addition, sampling techniques presently in the research realm but likely to be accessible soon, will also be discussed.
Microbiology
Objectives
To identify pathological microbes within the nose and sinuses, allowing culture-based antimicrobial treatment where appropriate, and to facilitate our understanding of the complex multifactorial aetiopathogenesis of inflammatory sinonasal disease.
Culture-dependent techniques
Nasal blown secretions
Culturing of nasally blown secretions is commonly utilized in the primary care setting and for paediatric patients. This is largely to circumvent the discomfort or inconvenience of nasal swabs. Patients are asked to nasally expel mucus which is then sent for microbiological testing. Although commonly used, than 100 individual allergenic molecules in a single analysis (112) .
Allergenic molecules still need to be cloned or purified to make them useable for diagnostic purposes, but wider possibilities will also increase costs (108) .
Total IgE
IgE antibodies are normally found in much lower concentrations in serum than other Ig classes such as IgG. In normal subjects, IgE levels increase from birth to adolescence and then decrease to reach a plateau after the age of 20-30 years. The standard curve for total IgE refers to the third World Health Organisation (WHO) standard and allows absolute determinations of unbound IgE concentrations (2.4 ng/ml = 1 IU/ml = 1 kU/l) (113) .
Indications for measuring total IgE may be if atopic disease is suspected, as an interpretation aid when judging specific IgE concentrations, or to correctly dose anti-IgE medication such as omalizumab.
Total IgE maybe increased in conditions other than atopy such as smoking and autoimmune, neoplastic or parasitic diseases.
In patients with atopic diseases total IgE may be moderately (>100 kU/l) to severely (>10,000 kU/l) increased. Substantially increased levels (> 20,000 kU/ml) should prompt diagnostic workup for cellular immune deficiencies, hypereosinophilia syndrome and lymphoma.
It has been suggested that some patients may have a local IgE immune response without elevated systemic IgE (114) . In a subset of patients the presence of specific IgE in the nasal mucosa has been demonstrated (115) , but the measurement of IgE in nasal secretions is currently not routinely performed.
Basophil activation test (BAT)
The basophil activation test is based on the fact that mast cells and basophil granulocytes share the same pathway for allergic degranulation after crosslinking of the high affinity receptor for IgE (FcεRI) by IgE and allergen on the cell surface (108, 116) . Individual basophils with allergic degranulation can be identified and distinguished from marginally activated basophils by upregulation of CD63 on activated basophils (117) .
Basophil reactivity has been shown to correlate with symptoms.
Some advantages of the BAT may increase its use in the future, including that the patient does not need to be exposed to the allergen, a number of single allergen molecules can be tested simultaneously as only 75-100 μl blood is required for a single test, allergen components can be combined to mirror real-life exposure, and CD63 upregulation is a precise marker of allergic degranulation and thus has the potential to reflect the severity of the allergic reaction (117) .
Recommendations
The clinical history helps to identify the need for allergy testing.
Skin tests are easy to perform and in widespread use, as are in only a few comparative studies exist comparing this to standard culture swab techniques. These studies suggest that a high concordance rate (>90%) exists for the detection of common upper airway pathogens when nasal secretions are present. In the absence of obvious secretions, this rate reduces to less than 50% (118, 119) .
Sinus aspirates
For many years maxillary sinus taps (MST) were considered the gold standard technique for obtaining sinus cultures (120) (121) . For these reasons, MSTs have fallen out of favour in recent times.
Nasal/sinus lavage
Nasal lavage is not considered an accurate technique for the culturing of sinus contents. This is because of the minimal sinus penetration that occurs in an unoperated patient as well as the inherent issues with nasal flora contamination. Direct sinus lavage and culture of the aspirated contents through an endoscopically placed maxillary sinus catheter does however circumvent these issues and may enable the practitioner to selectively collect the sinus efflux with less contamination.
Studies comparing direct sinus lavage to EDMM swabs have demonstrated higher bacterial yields and increased recovery of anaerobic pathogens (122, 123) , making some believe them to be more sensitive for the detection of fastidious and less abundant 
Culture-independent techniques
Next generation sequencing
Next generation sequencing techniques have allowed for the identification of micro-organisms previously unidentifiable on routine culture studies. Samples can be obtained using guarded, flocculated microbial swabs or by tissue biopsy with high concordance noted between the two (125) . DNA is extracted from the obtained specimens and sequenced using primers specific for conserved genetic regions within bacterial or fungal micro-organisms. Sophisticated bio-informatic pipelines that reference known microbial libraries then allow for the identification and relative quantification of all the microbial organisms present. Although previously confined to the research setting, such technology is now commercially available and accessible for clinical use. Studies comparing culturedirected analysis with next generation sequencing have shown significant discordance, with sinus culture poorly predicting resident microbiota (126) . This may in part explain the oftenpoor treatment response despite culture-directed antibiotic therapy. It is possible that the incorporation of modern cultureindependent techniques into clinical practice may improve treatment outcomes, but further research is required.
Outcomes
There is no evidence that microbiological assessment of nasal or sinus samples has any impact on outcomes in rhinosinusitis.
Although a recently published systematic review offers moderate evidence that antibiotics provide a small but significant benefit for clinical outcomes in immunocompetent patients with uncomplicated ABRS, 80% of individuals with ABRS typically improve within two weeks without treatment (127) . Furthermore, there is no evidence showing superiority of culture-directed antibiotic therapy over empiric treatment for this condition. For this reason, microbial sampling for uncomplicated ABRS is not routinely recommended (3) . The
European guidelines for the treatment of ABRS do however suggest that ABRS non-responsive to empirical antimicrobial treatment and topical nasal steroids, and complicated ABRS, should be referred to an ENT specialist. At that time, further diagnostic procedures including microbiology may be required (3) .
Although 
Chemosensory assessment
Rationale
For some senses it is sufficient to ask whether the person thinks that there is a dysfunction. This makes screening of that sense easy and asking about the function is reliable. Several studies have shown that this is not the case for olfaction (128) . The self-evaluation of olfactory function does not correlate with measured olfactory function, meaning that impaired sense of smell can be totally unnoticed by the patient and the doctor if it is not measured (128, 129) . Even in patients declaring that they have an olfactory impairment, the extent of dysfunction is constantly misevaluated (130, 131) . Only in patients with total anosmia does there seem to be a match between subjective smell loss and measured absence of olfactory function (130, 132) .
As a consequence, olfactory function needs to be measured if this parameter is intended to be part of any kind of study, measure of surgical success or clinical follow up of conservative treatment in rhinology. Simply asking about olfactory function is not enough. The same is true for gustatory function (133) . (134) .
Objectives
To measure chemosensory function by formally testing olfactory, gustatory and trigeminal function, through psychophysical and objective tests.
Olfactory testing
Olfactory tests can be roughly divided into three categories.
Olfactory identification
The overwhelming majority of olfactory testing is olfactory identification. This consists of presenting strong, suprathreshold concentration odours for the patient to identify.
Although this sounds easy, four things should be considered.
First, if the patient is not given a choice of answers, the likelihood that the results fail to reflect the true olfactory function is relatively high (135) . This is due to most people's inability to associate odours to a single odour identity without being given verbal help. If, for example, the odour presented is cinnamon, the patient needs to be offered a choice of descriptor items such as vanilla, chocolate, cinnamon and coffee ( Figure 6 ).
Second, this kind of testing is biased by cultural background. If cinnamon is presented in a region of the world where cinnamon is rarely used, even subjects with normal olfactory function will have poor results. This is probably the main reason for the number of different tests available, often with country-or cityrelated names (Table 4 ) (134, (136) (137) (138) . Third, the patients should be forced to choose one of the four descriptors ( Figure 6 ).
This forced choice sets the chance level for a descriptor to be chosen as 25%. A patient with no sense of smell at all (total anosmia) would still score some 'correct' answers if several odour presentations are done this way. Using a forced choice paradigm may thus help to identify malingering patients (139) . Finally, the number of odours used improves the validity of the test result.
The more odours are used in a forced choice identification test, the better the result assigns a patient to anosmia, hyposmia or Cinnamon Coffee
Vanilla Chocolate
Presented descriptors it is not unusual to see a typical pattern of normal olfactory identification with impaired thresholds (142) . The disadvantage of threshold testing is that it is done with a single odour. As humans have slightly different olfactory receptor ranges (143) , patients with isolated weakness for the odour used might falsely be considered hypo-or anosmic. Some of the widely used olfactory tests offer commercially available prefabricated thresholds whereas n-butanol and phenylethylalcohol (PEA, rose odour) are the most prevalent threshold tests (137, (144) (145) (146) .
Olfactory discrimination
This method consists of presenting three supra-threshold concentrated odours where two odours are the same and one is different. The goal is to identify the dissimilar odour. Like the identification test, this can be repeated several times and becomes more accurate the more odour triplets are used.
Retronasal olfactory testing
Odour molecules reach the olfactory epithelium via the nose (orthonasally) or retronasally (Figure 8 ) (147) . Retronasal olfactory perception is often taken to be taste perception by patients, but actually reflects the olfactory part of the flavour (148) . (134) . allows for clearer definition of the hyposmia range. This is why the most prevalent olfactory identification tests include at least 20 items (136, 138, 140, 141) .
Testing retronasal olfactory function alone may give valuable
Olfactory threshold
Threshold testing is the second most common test method.
It is fundamentally different in that it uses only one odour that is presented in different dilutions from physiologically not detectable to very concentrated. The task is to detect the presence of the odour, not identify it. The odours are presented to the patient in gradually increasing concentrations to the point where the patient reliably detects the odour. The concentration is then decreased again until the patient is no longer able to detect it. This up and down ('stairway') procedure is repeated several times until a reliable threshold is established.
Threshold testing is more time-consuming than identification tests but has the advantage of reliably detecting subtle olfactory loss, as is often the case in sinonasal disease (134) . In CRS patients
Olfactory bulb
Olfactory epithelium information in patients with sinonasal inflammatory conditions that tend to obstruct the anterior rather than the posterior airflow to the olfactory cleft (149, 150) . Retronasal testing has also been used in malingerers or patients trying to exaggerate their situation (151) . The literature on retronasal olfactory tests is not abundant and there is currently no commercial test available.
All published tests (150, 152, 153) are self-made and are identification tests based on the same principle as the orthonasal identification test described above (Figure 9 ).
These diverse methods test different aspects of olfactory function. Threshold testing reflects more peripheral changes such as those seen in sinonasal diseases, whereas identification and discrimination reflect more cognitive aspects of olfactory function (154, 155) . Other, more rarely used techniques are the odour memory test (156) that specifically addresses the capacity to memorize previously presented odorants, and the sniff magnitude test (157) or olfactory respirometry (158) that use sniff or inhalation pattern changes to draw conclusions about the perceived odour stimulation.
Testing olfactory function in children is more challenging as they may not always be familiar enough with odours or simply lack patience to do a full-length adult test. Some identification tests have recently been validated for use in a young population, but below the age of five years the classical identification testing paradigm is not helpful and other paediatric-specific tests should be used (159) (160) (161) (162) . Two very recent publications have addressed the biases that the classical psychophysical tests have, such as the genetic variability of odour sensitivity and cultural influences (163, 164) . The authors propose the use of mixtures instead of single odours for both identification and threshold testing, suggesting that this can overcome these biases. It is too early to see the impact this change will have but it might herald a new design for olfactory psychophysical tests.
Objective olfactory testing
Objective olfactory testing, using event related potentials (ERPs), was first described over 30 years ago by Kobal and co-workers (165) and can be considered a validated clinical tool that is no longer restricted to research. Unfortunately, the recording of ERPs is time consuming and the olfactometers very costly. This means that ERPs are only in routine use in a handful of clinics and are mainly reserved for insurance cases (166, 167) .
Gustatory testing
Although taste seems to be the much simpler sense in terms of complexity, its assessment is far behind that of olfaction.
Human taste comprises the modalities sweet, sour, salty, bitter, umami (or monosodium-glutamate) and, as recently identified, water (168, 169) . Whereas testing the first four modalities has been done for decades, there is still no routine testing of umami in a clinical setting. One reason is verbal confusion between taste modalities. In normal subjects without any taste problems, more than 20% would name the impression they had after the presentation of citric acid (sour) as bitter or salty. With the exception of sucrose (sweet), which is reliably identified by more than 95% of subjects, psychophysical taste testing is associated with a high degree of verbal confounders (170) .
There are two psychophysical ways of testing gustatory function. One is chemical testing with substances such as sucrose, citric acid, quinine or sodium chloride; the other is electrical stimulation of the gustatory areas of the tongue and oral cavity (electrogustometry) (171) . The first method has the advantage of selectively stimulating the taste fibres since activation is taste-receptor specific. The disadvantage is that it is time-consuming. Electrogustometry is quick and easy to perform. The disadvantage is that electrical stimulation not only elicits activation of gustatory fibres but also of free trigeminal (somatosensory) fibres. The result is a mixed taste-trigeminal perception that has the character of 'sour-stinging-prickling' (172) .
Gustatory testing has become more prevalent since commercially available tests with a longer shelf-life have become available. This is managed by drying the taste substance on diverse supporting agents such as candies (173) , Figure 9 . A retronasal test device based on food powders. The powders are applied by means of squeezable vials onto the subject's tongue. 
Recommendations
It is crucial to test rather than to ask. More extensive tests increase the diagnostic accuracy but are more time-consuming.
For general practitioners, a simple identification test is sufficient.
Specialized olfactory clinics require validated tests with a large database of normative data available (134) .
Imaging
Rationale
Imaging accurately visualises areas beyond the naked eye and endoscope. It is used to provide an accurate assessment of the anatomy, a corroboration of clinical symptoms and endoscopic findings and facilitates an objective evaluation of pathology both in terms of diagnosis and extent of disease (191, 192) . However, how and when the scan is done will influence the results. Computed tomography (CT) and magnetic resonance imaging (MRI) are amongst our most important diagnostic tools, and if a specific diagnosis is not possible based on the imaging, a differential diagnosis is usually provided. Furthermore, extent of disease can be defined and semi-quantified and MRI in particular allows soft tissue characterisation.
Pre-operative CT is mandatory for sinus surgery in most countries and should be available to the surgeon in the operating theatre. This became the standard of care with the advent of endoscopic sinus surgery (193, 194) and now often augments an appreciation of the anatomy through navigation systems and other techniques such as fusion of CT and MRI.
Imaging also has a major role in follow-up, where serial MRI may be undertaken without radiation exposure.
Objectives
To demonstrate anatomy and anatomical variants ( Figures 11   and 12 ), to define the pathology, both the diagnosis (Figures 13-17 ) and extent, as well as monitoring for disease recurrence. cellulose disks (174) or filter paper (175) . The development and validation of taste strips (175, 176) now allows easy and quick bedside testing of gustatory function ( Figure 10 ). However, only identification tests are currently available, with no gustatory threshold testing available.
Objective testing
Objective gustatory evaluation by ERPs has been shown to be feasible (177) but has not yet found its way into routine clinical practice (178, 179) .
Trigeminal testing
The trigeminal nerve provides the oral and nasal cavity mucosa with somatosensory innervation. As such it is part of the chemical senses via a series of TRP channels that recognize volatiles and molecules such as menthol and capsaicin. The three chemical senses (taste, olfaction and trigeminal) interact and influence each other in health and disease (180) (181) (182) (183) and full chemosensory investigation should include measurement of trigeminal function. Currently the investigation tools in this field are poor, although recent studies suggest that intranasal trigeminal function has an influence on how humans perceive airflow and is possibly linked to the sensation of nasal obstruction (184, 185) . Psychophysical trigeminal testing can be done by three methods. The first is to establish thresholds using volatile molecules that primarily stimulate the trigeminal system, such as eucalyptol or menthol, and create dilution series. The problem with thresholds is that olfactory sensitivity is far higher than trigeminal sensitivity so the measured threshold would reflect the olfactory rather than the trigeminal threshold of the substance. To overcome this requires subjects to disregard the odorous properties of the substance and to focus on trigeminal properties such as coolness, pricking or stinging (186) . The second method is to use a lateralization device. This test takes advantage of the fact that the olfactory system is unable to locate the source of stimulation whereas the trigeminal system can (187) . The third, most recently developed device uses the summation properties of the trigeminal system and analyses the concentration a subject is able to bear over time when exposed to a trigeminal stimulus such as carbon dioxide (188, 189) . There is a need for better intranasal trigeminal testing since none of these methods has yet found its way into routine rhinology workup.
Objective testing
In contrast to psychophysical testing, objective trigeminal evaluation by means of ERPs is well established. It has been developed in parallel to objective olfactory testing and is available in any clinic that offers objective olfactometry with ERPs (190) . Unfortunately, it has the same shortcomings of being costly and time-consuming.
Techniques
Neither plain x-ray nor ultrasonography are routinely used in modern rhinologic practice (3, 195) .
Computed tomography (CT) and cone beam CT (CBCT)
The technology and processing abilities of multi-detector CT (MDCT) scanners have continued to evolve and improve. There has been a drive to reduce radiation dose whilst preserving image quality by shortening the scan time and using postprocessing techniques (196, 197) . Cone beam CT (CBCT), historically used for dental imaging, is also being utilised in sinonasal imaging producing high resolution images, but the longer scan time, subsequent susceptibility to motion artefact and the lack of soft tissue differentiation can be a drawback. The reformatted images are best visualised interactively. By placing a marker on the area of interest (for example the uncinate process), its relationship to adjacent structures can be highlighted simultaneously in all three planes. The use of detailed three planar reconstruction has significantly improved our appreciation of the complex anatomy, particularly in the frontal recess, and led to international efforts to agree a classification of the area (3, 192) (Figure 12 ). Three-dimensional (3D) reconstructions are helpful when surgically planning complex facial trauma or craniofacial anomaly cases. 3D models can be made from the CT data using 3D printing techniques in order to plan or practice the surgery in advance and can be used to design bespoke prostheses.
More complex multi-planar reformatting, for example in curved planes for an orthopantomogram of the upper jaw, may be particularly useful when assessing dentition.
Magnetic resonance imaging (MRI)
MRI is recommended for soft tissue characterisation; it is useful Diffusion weighted imaging (DWI) is especially useful in the head and neck region for helping to differentiate posttreatment scarring from tumour and can be used in some sinonasal neoplasia such as squamous cell carcinoma for highlighting areas of concern. Post-treatment studies are difficult to interpret due to distortion of the normal anatomy, but foci of restricted diffusion can help the radiologist identify suspicious areas that can then be reviewed on other (T1/T2 and post-gadolinium) sequences and by direct inspection. DWI has been used to identify those tumours that are responding to chemoradiotherapy. Imaging can be performed during treatment to assess response and may in the future have a role in adjusting the treatment regime (198) . Dynamic contrast enhanced MRI (DCE-MRI) and intravoxel incoherent motion (IVIM) are two MRI techniques that have been shown to effectively differentiate between benign and malignant sinonasal lesions, although biopsy is still required to identify the exact pathology (199) .
There are some contraindications to MRI imaging such as 
Sensitivity and specificity or accuracy
Studies comparing symptoms with CT and endoscopic findings have shown good correlation between CT and endoscopy but not between symptoms and CT. When comparing concordance between endoscopy and CT staging in CRS, the correlation was 65% for positive and 71% for negative results (200) .
Many attempts have been made to semi-quantify the changes observed on CT scan using scoring and staging systems of varying complexity. The most commonly used of these is the Lund-Mackay system which is based on the degree of opacification of the maxillary, anterior and posterior ethmoids, frontal and sphenoid sinuses (0-none; 1-partial; 2-complete) and OMC (0 or 2) giving a maximum score of 24 or 12 per side (201) . This scoring system has been validated in several studies (202, 203) but does not significantly correlate with symptom severity scores.
CT and MRI are extremely sensitive in demonstrating 'abnormalities' in the sinonasal region. A wide range of anatomic variations are observed which are generally unrelated to the development of disease (204, 205) but are highly significant for 'safe' surgery, such as the presence of a sphenoethmoidal cell. The development of the frontal and sphenoid sinuses during childhood to early adulthood has been demonstrated by imaging (191, 206) .
Marked inflammatory changes may be observed following a viral cold which can persist for a number of weeks (207, 208) which probably accounts for the high percentage of normal asymptomatic adults who have evidence of mild mucosal thickening on CT (~18% ) (204) . Thus on CT a 'normal' Lund-Mackay score (LMS) for adults is 4.26 (95% CI, 3.43 to 5.10) (209) and for children it is 2.81 (95% confidence interval, 2.40 to 3.22), with only 19.3% having a score of 0 (210) . The LMS can also be applied to MRI and does not appear to overstage inflammatory disease (211) .
Conversely more than 40% of patients who fulfil the symptombased diagnosis of CRS may have normal CT and endoscopy results (3) . The accuracy of CT in the diagnosis of CRS was tested, comparing CT scores with histopathologic grade of inflammation and including a control group without CRS utilizing well designed criteria. By using the ROC method, the sensitivity of CT was found to be 94% and specificity 41% using a LMS score cut-off value for CRS of greater than two. If the value of 'normal' LMS scores (greater than 4) was applied, specificity increased to 59%. Using the same method in paediatric rhinosinusitis, taking an LMS of at least five to indicate real disease, CT sensitivity was 86% and specificity 85%. Thus, LMS of two or less have an excellent negative predictive value, and LMS of five or more have an excellent positive predictive value, strongly indicating true disease. By comparison plain sinus radiographs have shown poor sensitivity and specificity, so that even low irradiation does not justify their use. Correlation of CT scans with plain sinus radiographs for maxillary sinusitis was reasonable (78%), but was only 52% for the ethmoids (212) . The pattern of inflammation may also be important. A central radiological pattern of mucosal disease is likely associated with inhalant allergen sensitization -the so-called 'black halo' sign (213) . The radiological pattern defined by centrally limited changes in all of the paranasal sinuses was associated with allergy status and predicted atopy with 90.82% specificity, 73.53% positive predictive value, likelihood positive ratios of 2.16 and diagnostic odds ratio (OR) of 4.59. In the management of tumours, specific diagnostic features may be found, for example erosion of the upper medial pterygoid plate in juvenile angiofibroma (214) or the likely diagnosis and site of origin in inverted papilloma ( Figure 15) (194, 215) . In malignant tumours treated by craniofacial resection, it has been possible to assess the accuracy of both CT and MRI compared with histological findings. With a dedicated head and neck radiologist CT versus histology was 85.2% accurate, whereas MRI with gadolinium DTPA correctly predicted the histology in 98.3% but even today still fails to determine microscopic involvement of the orbital periosteum and dura (216) .
Imaging of the olfactory bulb has become an area of increasing importance as interest has increased in olfaction in general and in particular the recognition of the role of olfactory loss in neurodegenerative disorders (217, 218) .
Outcomes
In the diagnosis and management of most rhinologic conditions, CT remains the gold standard. However, with the exception of neoplasia, extent of disease does not necessarily equate with prognosis.
In a multicentre prospective study of patients undergoing surgery for CRSwNP (Figures 16 and 17 ) and CRS without nasal polyps (CRSsNP), the LMS was correlated with a range of parameters in 1840 CT scans (219) . This showed unsurprisingly that the higher the score, the higher the grade of polyp and the more extensive the surgery. The score also correlated with symptom reduction (coeff=0.24, p=0.02), complication rate (OR 1.08, 95% confidence interval (CI) 1.06-1.1) and revision rates (OR 1.03, 95% CI 1.001-1.06) but showed no correlation with SNOT-22 scores. In contrast, a more recent study (220) showed that the preoperative LMS in 665 patients with medically recalcitrant CRS correlated significantly with preoperative extranasal and rhinologic symptom severity on the SNOT-22 and that the LMS was an indicator of postsurgical QOL outcomes.
Nonetheless it seems that the LMS measures a different aspect to 'subjective' symptom scores as it correlates well with other markers of disease severity, the nature of surgery offered and its outcome. Its main value lies in diagnosis, determining extent of disease and providing inclusion criteria for studies. However, it cannot be used as an outcome measure due to ethical issues with post-therapeutic scanning with additional radiation exposure.
Other radiologic features such as the degree of neoosteogenesis in CRS may have important prognostic implications (221, 222) .
Recommendations
In most current consensus documents (3, 195) CT is the modality of choice in the radiologic evaluation of rhinologic disease, notably CRS. However, in ARS, the diagnosis is made on clinical grounds and CT is not recommended (191) unless the condition persists despite treatment or a complication is suspected, when contrast is used if there is no contraindication (223) . However, a recent study from Spain suggested that CT continues to be over-used in this context (224) .
In CRS, CT imaging is the primary modality but is not normally recommended until after an appropriate course of medical therapy has failed (3, 195) and without an intervening acute episode. It is mandatory prior to surgical intervention when three planar CT is advisable, particularly for assessment of frontal sinus drainage. It should be noted that, radiation exposure aside, other studies suggest that early CT scanning may be more cost-effective as compared to extended courses of antibiotics given empirically (7, 225) . This is especially pertinent in patients with rhinitis or atypical facial pain (226) (227) (228) and may be facilitated by the availability of lower radiation protocols and/ or CBCT.
A combination of CT and MRI are generally recommended to assess the extent of tumours with sequential MRI utilised for long-term follow-up (229, 230) .
Nasal sampling for inflammatory markers
Rationale
The measurement of inflammatory and other biological markers in nasal secretions and cells can potentially provide diagnostic and therapeutic information regarding different sinonasal disease processes. In general, the most common techniques for nasal sampling are nasal lavage fluid, nasal suctioning, inserting nasal packs, nasal brushing or scraping, and biopsies.
The most important determining factor for which method to use is whether inflammatory markers, nasal cells for cytology or culture, or a combination of both are required.
Objectives
To obtain appropriate nasal secretions, fluid and/or cells to allow measurement of relevant biological markers, to aid in the diagnosis, treatment and understanding of the pathophysiology of rhinologic disease processes.
Techniques
Nasal blown secretions
The easiest method to collect nasal secretions is by simply blowing the nose and collecting the mucus in sterile containers directly or by letting the participants blow in tissues (118) .
This method is especially helpful in children. The biggest disadvantage is the small quantities of mucus obtained with this method.
Nasal lavage
Lavage fluid is introduced into the nose for a certain amount of time and then recollected, with its associated nasal secretions.
It is easy to perform and well tolerated. Various techniques are used, mainly differing in the amount of lavage fluid used and the time left inside the nose. The lavage fluid consists of 0.9% sodium chloride (NaCl) at body temperature and is instilled via a syringe. It is important to instruct the patient not to swallow the fluid while the head is reclined. After the appropriate waiting time the head is bent forward and the lavage fluid collected in sterile containers. Usually 2-10mL of NaCl are introduced for approximately 10 seconds (231, 232) . The 'rule of 10' can be applied for facilitating the protocol: use a 10mL syringe to instil 10mL of NaCl for 10 seconds in each nostril. To reduce the volume of fluid inserted into the nose to 1-5mL one can use nasal sprays with iso-to mildly hypertonic saline (0.9-1.8%) (232) . Variations of nasal lavage have been described, including inserting a paediatric tracheostomy tube into the nostril and inflating the cuff after the patient bends forward, so as not to lose lavage fluid and be able to standardize volumes better (233) . A disadvantage of the nasal lavage techniques is that by instilling NaCl the mucosa is stimulated, which may bias the results.
Nasal suctioning
Nasal suction devices are sterile and contain a reservoir where nasal secretions can be trapped (Figure 18 ). For post-processing it is important to weigh the reservoir prior to application to avoid bias through minimal weight differences of the product.
The exact weight of the sample can then be determined.
The mucus can be suctioned out and directly frozen at -80 to -90°C before further processing or a known quantity of phosphate buffered saline (PBS) or similar agents can be applied immediately after suctioning and before freezing. The advantage of this may be to stop chemical activity such as proteolysis in the mucus (234) . This technique is well tolerated and has the advantage of minimal stimulation and/or trauma to the mucosa. Moreover, certain areas of the nose can be directly suctioned under endoscopic control, for example the middle meatus or the olfactory cleft (235) .
Nasal packing
Nasal packing in a variety of commercially available forms can be used to soak up nasal secretions. The packs can be placed in different areas of the nasal cavity from where secretions are specifically required (e.g. inferior or middle meatus). They must be weighed before and after insertion into the nose to measure the quantity of absorbed secretions. The packs are left in situ for five minutes and are then placed in a conical tube, washed in NaCl and mechanically squeezed out (e.g. with a syringe), then washed again and centrifuged at 1500 g for 10 min at 4°C to obtain all secretions (236) . An advantage of this method is clear discrimination of sides as compared to lavage techniques.
However, disadvantages include patient discomfort, irritation of the mucosa and that nasal secretions might be retained in the pack despite thorough squeezing and washing. Moreover, if nasal secretion at baseline is low, a limited amount of material would be collected (e.g. in a study control group). Another technique uses reticulated polyurethane foam packs (at 60 and 110 pores per inch (PPI)) that perhaps absorb secretions better than standard packs with less stimulation of the mucosa (237) .
Nasal brushing
Nasal brushing can be performed with a soft sterile brush in the middle or inferior meatus with a gentle circular movement ( Figure 19 ). The brushes are then immersed in tubes containing an appropriate growth medium depending on the subsequent processing. The tubes are vortexed for five minutes and intermittently the brushes are gently rubbed by forceps to remove the sample from the brush hairs. The tube is then centrifuged at 400 g for 10 minutes. Depending on further experiments the supernatant can be discarded or the mucus it contains may be used for further analysis (238) . With this method pure cytology can also easily be performed. The advantage is to be able to obtain both mucus and enough cells for cell culture. A disadvantage is the discomfort for the patient as well as trauma to the mucosa which may contaminate the sample with blood.
Nasal scraping may also be used for cytology but probably yields less cells for cell culture. Nasal scrapings have been shown to be more reliable than swabbing (239) .
Nasal biopsy
The nose is the most accessible part of the respiratory tract and is therefore an invaluable source of respiratory tissue. For research purposes, the biopsy must be easily performed, painless and with a minimal complication rate. For clinical diagnosis the need for sufficient sample size has to be balanced with the burden for the patient. It is important that the biopsy is not crushed. This can be achieved with specific Fokkens forceps ( Figure 20) (240) or more general fenestrated punch forceps (241) , or in the operating theatre with scissors (242) .
Biopsy of intranasal tissue can help in the investigation
Small biopsies for research purposes can be taken from the inferior turbinate after local anaesthesia. We place cotton-wool with 50 to 100 mg of cocaine and three drops of epinephrine (1:1000) under the inferior turbinate without touching the area from which the biopsy specimen is taken, but a small pledget of cotton wool with 50 mg of cocaine resting on the floor of the nose between the inferior turbinate and the septum has also been described (241) . Especially in research, when repetitive biopsies have to be taken, it is essential that the procedure is painless and does not cause bleeding. This is difficult to achieve with less potent local anaesthetics such as lidocaine.
For light microscopic evaluation, the biopsy specimens can be embedded in Tissue-Tek II OCT compound in a gelatin capsule and frozen immediately. The minimum number of sections required to give a sufficient number of fields to assure acceptable accuracy (5%) was determined to be two on the basis of a summation average graph (243) . In general cells can be evaluated more reliably in biopsies than in nasal brushings or swabs (244) . This might be especially important when the inflammatory response is not always obvious, as in non-allergic rhinitis (245) . It has been shown that biopsies can safely be taken from the olfactory mucosa without affecting nasal function or the sense of smell (246) .
Recommendations
Nasal sampling can be undertaken when measurement of specific inflammatory or other biological markers is required but it remains predominantly a research tool at present. The technique used depends on the type of sample required (mucus, mucosa, cells) and the marker to be studied.
Objective measures of nasal airflow and patency
Rationale Nasal obstruction is a common complaint in many nasal conditions and affects QOL (247) , so its objective measurement is very important (248, 249) . Many authors have shown that the correlation between the subjective sensation of nasal obstruction and its objective measurement is low or absent (250) (251) (252) . However, others have reported a correlation, both in adults (253) (254) (255) (256) (257) (258) (259) and children (260) . In the lower airways, symptoms are assessed and monitored by pulmonary function tests (261) .
Similarly, nasal obstruction assessment with objective measures should become part of routine clinical testing (262, 263) .
Objective measures such as peak nasal inspiratory flow (PNIF), rhinomanometry (RM) and acoustic rhinometry (AR) assess different aspects of nasal obstruction and provide complementary information (264) . RM and AR are the most commonly used methods and have shown good correlation with each other (254, (265) (266) (267) . PNIF has shown a moderate to strong correlation with both AR and RM (268) . Van Spronsen et al. proposed the GRADE system (Grading Recommendations Assessment, Development and Evaluation) to evaluate studies of different tools used to assess nasal obstruction and concluded that RM and PNIF were good for assessing the presence and severity of obstruction (269) . In this section, these methods will be analyzed and discussed in detail.
Objectives
To provide objective measurements of nasal airflow and patency to assist in the diagnosis and assessment of nasal obstruction, and to monitor response to treatment, both medical and surgical.
Peak nasal inspiratory flow (PNIF)
PNIF is an inexpensive, fast, portable and simple technique which does not depend on computers to analyze the data. PNIF uses a facemask with an airtight seal over the nose and mouth, attached to a peak flow monitor ( Figure 21 ). The patient, sitting upright, exhales fully then holds the mask in place and inspires through the nose as hard and fast as they can, keeping the mouth closed (264) . Usually three satisfactory maximal inspirations are obtained and the highest of these results is taken as the PNIF value (270) . PNIF strongly decreases with age (270) (271) (272) (273) , is higher in males than females and increases with height, albeit with a large variability (270) . This variability can perhaps in part be explained by the correlation of PNIF and pulmonary function, specifically peak expiratory flow rate (PEFR) (274, 275) . Normal PNIF values are available for adults and children (270, 273, (276) (277) (278) (279) (Table 5 ). Unilateral normal PNIF values are available for adults (280) .
Given its portability and simple technique, PNIF can be easily used by the patient in the workplace to evaluate environmental effects on nasal airflow (281) and can be used at home to investigate the day-to-day effects of therapy on nasal airflow (282, 283) . PNIF has good reproducibility (284, 285) with a correlation coefficient up to 92% (286) .
Despite the potential for valve collapse at high flow rates (287) and the need to pay attention to the nasal valve area especially when unilateral measurements are taken (288, 289) , PNIF has been used to study nasal valve collapse (290) and to evaluate the effect of nasal dilators (291) (292) (293) (294) (295) and surgery for nasal valve insufficiency (296, 297) .
Rhinomanometry (RM)
RM is the simultaneous measurement of nasal airflow and the pressure gradient required to achieve that flow from which nasal airway resistance (NAR) can then be calculated (298) . RM Figure 21 . A young patient performing peak nasal inspiratory flow.
can be anterior or posterior, active or passive. In anterior active rhinomanometry (AAR), the most commonly used method of RM (299) , a mask is attached to the device that measures the transnasal pressure and flow and interfaces with a computer.
The pressure sensor is placed in one nostril with a total seal created by taping off the nostril (Figure 22 ) (299) . NAR is the ratio of pressure to flow and is reported in Pa/cm 3 /sec (300, 301) .
Simultaneous display of the pressure-flow curve is provided. The more obstructed the airway, the greater the pressure required to generate a certain flow. The International Committee on Rhinomanometric Standards previously described calculating NAR at a fixed pressure gradient of 150 Pa (P150) in classic AAR (298) . More recent consensus guidelines recommend the use of four-phase rhinomanometry (4PR), where NAR is calculated using hundreds of resistances continuously recorded during the whole breathing cycle (299, 302) . In 4PR the parameters considered are: 1) vertex resistance (VR), defined as the resistance measured at the highest point of the flow curve during quiet breathing, and its logarithmic value (LVR); 2) the effective resistance of the entire breath (Reff ); and 3) the effective resistance during inspiration (ReffIn) and expiration (ReffEx) and their logarithmic values (LReff, LReffIn and LReffEx). VR has been found to best correlate with the symptom of nasal obstruction (303) . Despite the differences in measurement techniques, 4PR and AAR have not been shown to significantly differ in outcomes (304) . More studies comparing these methods should be performed in the future.
Rhinomanometry can be carried out in children; NAR decreases with age and is lower for girls than boys (305) . Reference values are available for children and adults (Table 5 ) (260, 306, 307) . Normal values for 4PR have also been reported (308, 309) .
Acoustic rhinometry (AR)
AR aims to explore the geometry of the nasal cavity. It uses the acoustic reflection of a sound wave that travels along the nasal cavity to measure areas and volumes at different points in the nose. Jackson et al. developed the fundamentals of AR in 1977 ( Figure 23 ) (310) . The size and pattern of the reflected sound waves provide information on the structure and dimensions of the nasal cavity, with the time delay of reflections correlating with the distance from the nostril. The conversion of these measurements to nasal volume and area requires mathematical calculations and theoretical assumptions, and is done by the computer connected to the recording device.
The patient sits in an upright position, cleans the nose and places the nosepiece into the nostril with an airtight seal ( Figure 24 ). The room should be standardized in terms of temperature and humidity. Silence during measurement is Figure 22 . A patient performing anterior active rhinomanometry. Nosepieces should either be disposable or treated with appropriate hygienic precautions in order to avoid transmission of infectious diseases (311) .
AR was standardized in 2005 by the Standardization Committee on Objective Assessment of the Nasal Airway of the European Rhinologic Society (312) . The distance from the nostril is calculated by the running time of the incident and reflected sound waves.
Derived parameters include nasal cavity volume, and minimal cross-sectional area (MCA) at the nasal valve and the anterior end of the inferior turbinate. Two notches, representing specific areas in the nose, are seen on the AR graph ( Figure 25 ). The first notch, or I-notch, is generally thought to be at the nasal valve. Since it has no precise anatomical correlation, it is strictly accepted as an AR measure. The absence of nasal mucosa at this point means that it will not be modified by vasoconstrictors (313) . The second notch, or C-notch, is located a mean distance of 1.83 cm from the nostril, with an average cross-sectional area of 0.56 cm 2 in a non-decongested nasal cavity, and is anatomically correlated with the head of the inferior turbinate. In healthy Caucasians, MCA corresponds to the second notch and is the AR measure of greatest clinical value; MCA less than 0.4 cm 2 correlates with nasal obstruction (314) . Volume values can be obtained in the nasal passages at various distances from the nostril; the volume between 2 cm and 5 cm in the nasal cavity is the most sensitive measurement for showing changes in the nasal airway after decongestion of the nasal mucosa (315) .
It is difficult to define a 'normal' nasal fossa. Countless variables must be taken into account in the context of mid-facial growth and development, as well as aspects linked to ethnic/racial characteristics, age, weight and the tools used. Separate left and right anatomical nose adaptors probably provide better results than measurements obtained with a common adaptor for both sides. Incorrect positioning and inclination of the sonic tube are the major source of errors (249) . Septal perforation influences the results of AR. Mishima et al.
studied this effect before and after closing a septal perforation by thin cotton patches (316) . The authors reported a decrease in MCA and volumes after closure. Compared to CT scan, AR measurements have been shown to accurately reflect the geometry of nasal cavity volumes in patients with nasal polyps, with a better assessment in the anterior part of the nasal cavity (317) .
Uses
All three tests can be used for the objective evaluation of nasal obstruction associated with CRS (301, (317) (318) (319) (320) (321) (322) (323) and allergic rhinitis (323) (324) (325) (326) (327) (328) (329) (330) (331) . Pre-and post-decongestion testing can distinguish between nasal obstruction due to soft tissue and that due to fixed structural deformity (249, 332, 333) (Table 6 ). This can be useful in the appropriate selection of surgical procedures (314, 334) as well as in the evaluation of nasal surgery outcomes (288, 289, (334) (335) (336) (337) (338) (339) (340) (341) .
Patients who have objective evidence of nasal obstruction do significantly better after nasal surgery than those who do not (314, 342) .
They can also be used to study the nasal cycle (343, 344) and hormonal influences on the nasal mucosa (345, 346) as well as in nasal provocation testing (328, (347) (348) (349) (350) (351) . AR is reportedly better than AAR for the nasal provocation test, since it measures the MCA and volume of the nasal passages quickly, directly and with high sensitivity and specificity. The nasal provocation test is considered positive if the MCA and/or the nasal volume between 2 cm and 5 cm decrease by at least 25-30% (352) (353) (354) . Table 5 . Normal values for peak nasal inspiratory flow (PNIF) (279, 281) and anterior active rhinomanometry (AAR) (308) . 
Nasal nitric oxide
Rationale
Nitric oxide (NO) is a colourless, odourless gas that is present in air exhaled through the mouth or nose. NO is produced from arginine and oxygen by nitric oxide synthase (NOS).
Constitutively expressed neuronal and endothelial forms exist as well as an induced form, iNOS, which appears to be upregulated within the respiratory tract in response to pro-inflammatory signals. NO came to prominence for its role in vasodilatation and subsequently as a neurotransmitter and inflammatory mediator (355) . The role of NO in the airways is complex, possibly including antibacterial effects, pro-inflammatory effects and regulation of blood flow and ciliary beat frequency. Exhaled NO (eNO) levels are raised in eosinophilic asthma and measurement of this has become a standardised, but not yet widespread, tool in the diagnosis and management of asthma (356) . It can potentially provide a rapid, low cost objective measure of lower airway inflammation. Most NO is produced in the sinuses, far less by the nasal mucosa and the lower respiratory tract (355) . 
Objectives
Nasal NO
High levels of NO are produced constitutively within the paranasal sinuses of normal individuals by calcium-independent NOS (355) . Additionally, NO is also formed in the respiratory mucosa by iNOS in response to inflammation. NO and its metabolites are toxic to micro-organisms and likely form part of the innate defence mechanism of the respiratory tract. NO may also stimulate ciliary beat frequency within the epithelium and regulate nasal vascular tone.
Technique
As with eNO, nNO can also be measured by chemiluminescence, using non-invasive techniques, providing immediate results.
Several different techniques have been used to ensure sampling from the upper airways only, including breath holding and breathing against resistance. Guidelines for measurement have been published (357) (358) (359) .
Diagnostic accuracy
Nasal NO can be measured in either nostril and shows no diurnal variation. The measurement is quick, reproducible, feasible and best accepted with an aspiration flow of 700 ml/min during breath-holding for 10 seconds (360) . Humming during nNO measurement initially increases levels considerably in healthy subjects (361) . If low values are obtained, measuring nNO during humming can increase the specificity of the measurement (362) . Healthy controls usually have nNO levels above 300 ppb (363) . In allergic rhinitis, nasal nitric oxide is elevated compared to healthy controls and correlates with the severity of the inflammation, as long as the ostia to the sinuses are open (364) . In nonallergic rhinitis, the level of nNO is reported to be comparable to healthy controls (364) . Measurement of nNO in CRSwNP and CRSsNP is hampered by the opposing effects of increased nNO due to inflammation and decreased nNO due to obstruction of the sinus ostia (355) .
Diagnostic use of nNO
PCD is a rare disorder causing chronic otosinopulmonary disease, generally diagnosed through evaluation of respiratory ciliary ultrastructure and/or genetic testing (see section on 'Tests of mucociliary clearance'). Nasal NO is a sensitive and specific test for PCD in cooperative patients (generally over five years old) with a high clinical suspicion for the disease. Nasal NO testing using palatal closure manoeuvres has diagnostic accuracy similar to electron microscopy and/or genetic testing for PCD when CF has been ruled out (365) . Nasal NO values below 77 ppb are very suggestive of PCD but higher values are occasionally found ( Figure 26 ) (363) . CF also has generally low values (70-300 ppb), and the presence of nasal polyps is associated with significantly lower nNO levels than in CF patients without nasal polyps (366) .
Nasal NO values in patients with allergic rhinitis, CRSsNP, CRSwNP, asthma and chronic obstructive pulmonary disease can be in the normal range or increased (361, 367) but when sinus ostia are closed nNO may also decrease. For that reason, nNO measurements are not very helpful in these patient groups.
After endoscopic sinus surgery for nasal polyposis, nNO levels increase significantly, but usually not to normal levels (366, 368, 369) .
Recommendations
Nasal NO is a sensitive and specific test for PCD in cooperative patients (generally over five years old) with a high clinical suspicion for this disease. To a lesser extent it may also be a useful adjunct in a potential diagnosis of CF. Whilst not commonly used as a specific diagnostic tool in allergic rhinitis and CRS, it may be used to monitor the response to treatment in these conditions.
Tests of mucociliary clearance
Rationale
In paediatric patients presenting with a long history of uncontrolled CRS with bilateral anterior rhinorrhoea and otitis media with effusion, one should consider evaluating the mucociliary clearance system for exclusion or diagnosis of PCD (370, 371) .
By their coordinated movement, the cilia lining the respiratory epithelium transport the mucus layer with entrapped inhaled particles from the nasal cavity towards the hypopharynx.
In physiological circumstances, about 10 ml of mucus is transported daily from the sinonasal cavities towards the hypopharynx, ultimately being swallowed and cleared from the upper airways. Normal mucociliary transport (MCT) is 
Objectives
Objective evaluation of the mucociliary clearance of the upper airways in order to quantify the ciliary function of the upper respiratory tract epithelium.
Techniques
Mucociliary clearance time
The MCT mechanism ensures the clearance of entrapped particles in the mucus lining the nasal mucosa towards the hypopharynx. Several non-absorbable substances have been used for the evaluation of MCT in patients.
The saccharine test evaluates the time taken to experience a sweet taste after placement of a 1-2 mm particle of saccharine on the inferior turbinate mucosa, 1 cm from the anterior end.
The patient must sit quietly with the head bent forward and without sniffing, coughing, sneezing, drinking or eating during the investigation. Alternatively, one can monitor the time needed for a dye such as methylene blue to be transported from the mucosa of the anterior third of the nasal cavity towards the hypopharynx. Other substances including technetium-99m-labeled iron oxide have also been used. The mucociliary clearance (MCC) time is considered to be normal below 15 minutes and should be less than one hour.
As the MCC time can only be measured in cooperative patients with patent nasal cavities and in the absence of severe mucosal disease, it has limited diagnostic value in certain patients. It also has low sensitivity and specificity and requires significant time investment. In the context of the clinical relevance of MCT, it has recently been demonstrated that nasal lavages, a commonly recommended treatment for many sinonasal conditions, reduce the MCC time (372) .
Electron microscopy
Harvesting epithelial cells is performed by scraping along the inferior and middle turbinates with a sterile cytology brush (see section on 'Nasal sampling'). These epithelial cells can be used for either structural investigation of the cilia with electron microscopy (EM) or for measuring ciliary beat frequency (CBF) in vitro.
In primary and secondary ciliary dysfunction, several abnormalities may be observed in the ciliary ultrastructure including total or partial absence of dynein arms, aberrant organization of the dynein arms and/or disorientation. PCD is associated with the latter abnormalities but SCD may also present with these structural abnormalities. Therefore, EM evaluation of harvested epithelial cells may aid in the diagnosis of PCD but is not 100% sensitive or specific.
Ciliary beat frequency measurement
Harvested epithelial cells can be evaluated for ciliary beat frequency (CBF) and the ciliary wave form analysed in detail by digital high-speed video imaging. The evaluation of the CBF as well as assessment of their coordinated movement can be performed by computerized programs using a Fast Fourier analysis. Normal values of CBF vary depending on the methodology used, the age of the patient and the culture conditions. The demonstration of normal CBF and beat pattern excludes the diagnosis of PCD.
Recently, a novel technique for quantification of CBF has been reported using phase-contrast microscopy images, estimating ciliary motion by means of an optical flow algorithm (373) . A ciliary motility index might discriminate between healthy and infected epithelial cultures (374) .
Ciliogenesis in vitro
The evaluation of ciliogenesis in vitro is considered the gold standard for diagnosis of PCD, allowing the differentiation between primary and secondary ciliary dyskinesia (375) 
Recommendations
No ideal test is available for the diagnosis of PCD in routine practice (376) . In cases of suspected PCD in a patient with CRS since birth, a family history of PCD and/or associated features of Kartagener syndrome (situs inversus and infertility), one should consider diagnostic tests of ciliary function by evaluation of CBF, EM evaluation of the dynein arms of the cilia and/or evaluation of the cilia after ciliogenesis in vitro. In a tertiary referral centre, one third of patients referred with suspected PCD are eventually diagnosed with the condition (377) .
As these techniques are not available in routine ENT practice, one should rely on measuring nNO levels in cases of suspected PCD; low nNO levels have been associated with PCD and therefore represent an excellent screening tool (see section on 'Nasal nitric oxide'). In addition, screening for genetic mutations known to be associated with PCD, as well as genetic counselling, is recommended (378) .
